Gastroenterology RSS : Gourt
http://www.gourt.com/Health/Medicine/Medical-Specialties/Gastroenterology.html
en-usCopyright 2007, Gourt.com2010-02-07T03:36+06:00
rtruog@gourt.comrtruog@gourt.comGastroenterology RSS : Gourthourly11901-01-01T00:00+00:00University City :: Kentucky :: Medical Search Consultants
http://www.physemp.com/physician_jobs/perma_gastroenterology_jobs_in_kentucky/page_2.html
Great Location :: Maryland :: Intelligent Placement Solutions, Inc
http://www.physemp.com/physician_jobs/perma_gastroenterology_jobs_in_maryland/page_3.html
Great Location :: Massachusetts :: Intelligent Placement Solutions, Inc
http://www.physemp.com/physician_jobs/perma_gastroenterology_jobs_in_massachusetts/page_2.html
Great Location :: Maryland :: Intelligent Placement Solutions, Inc
http://www.physemp.com/physician_jobs/perma_gastroenterology_jobs_in_maryland/page_4.html
Great Location :: North Carolina :: Intelligent Placement Solutions, Inc
http://www.physemp.com/physician_jobs/perma_gastroenterology_jobs_in_north_carolina/page_6.html
Great Location :: West Virginia :: Intelligent Placement Solutions, Inc
http://www.physemp.com/physician_jobs/perma_gastroenterology_jobs_in_west_virginia/page_1.html
Great Location :: North Carolina :: Intelligent Placement Solutions, Inc
http://www.physemp.com/physician_jobs/perma_gastroenterology_jobs_in_north_carolina/page_7.html
Great Location :: Florida :: Intelligent Placement Solutions, Inc
http://www.physemp.com/physician_jobs/perma_gastroenterology_jobs_in_florida/page_8.html
Great Location :: Virginia :: Intelligent Placement Solutions, Inc
http://www.physemp.com/physician_jobs/perma_gastroenterology_jobs_in_virginia/page_2.html
Great Location :: Georgia :: Intelligent Placement Solutions, Inc
http://www.physemp.com/physician_jobs/perma_gastroenterology_jobs_in_georgia/page_5.html
Great Location :: Virginia :: Intelligent Placement Solutions, Inc
http://www.physemp.com/physician_jobs/perma_gastroenterology_jobs_in_virginia/page_3.html
Great Location :: Texas :: Intelligent Placement Solutions, Inc
http://www.physemp.com/physician_jobs/perma_gastroenterology_jobs_in_texas/page_3.html
Not Disclosed :: Michigan :: Locum Medical Group
http://www.physemp.com/physician_jobs/perma_gastroenterology_jobs_in_michigan/page_1.html
Not Disclosed :: Texas :: Locum Medical Group
http://www.physemp.com/physician_jobs/perma_gastroenterology_jobs_in_texas/page_6.html
NorthWest :: Arizona :: Intelligent Placement Solutions, Inc
http://www.physemp.com/physician_jobs/perma_gastroenterology_jobs_in_arizona/page_2.html
SouthEast :: North Carolina :: Intelligent Placement Solutions, Inc
http://www.physemp.com/physician_jobs/perma_gastroenterology_jobs_in_north_carolina/page_1.html
Central :: Colorado :: Intelligent Placement Solutions, Inc
http://www.physemp.com/physician_jobs/perma_gastroenterology_jobs_in_colorado/page_2.html
North :: North Carolina :: Intelligent Placement Solutions, Inc
http://www.physemp.com/physician_jobs/perma_gastroenterology_jobs_in_north_carolina/page_8.html
South :: South Carolina :: Intelligent Placement Solutions, Inc
http://www.physemp.com/physician_jobs/perma_gastroenterology_jobs_in_south_carolina/page_8.html
East :: Pennsylvania :: Intelligent Placement Solutions, Inc
http://www.physemp.com/physician_jobs/perma_gastroenterology_jobs_in_pennsylvania/page_18.html
Electronic Communications with Patients: Improved Safety, Improved Access, or Electronic Leash-Principles and Prospects.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=20135226&dopt=Abstract
The Yield of a Continuously Patent Gastroesophageal Junction During Upper Endoscopy as a Predictor of Esophagitis in Children.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=20135227&dopt=Abstract
Role of transcatheter arterial embolization for massive bleeding from gastroduodenal ulcers.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=20014452&dopt=Abstract
Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=20014453&dopt=Abstract
Colorectal cancer screening in Europe.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=20014454&dopt=Abstract
Progress in researches about focal adhesion kinase in gastrointestinal tract.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=20014455&dopt=Abstract
TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapies.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=20014456&dopt=Abstract
Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=20014457&dopt=Abstract
Ketoprofen, peginterferon 2a and ribavirin for genotype 1 chronic hepatitis C: a phase II study.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=20014458&dopt=Abstract
Education-based approach to addressing non-evidence-based practice in preventing NSAID-associated gastrointestinal complications.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=20014459&dopt=Abstract
Hyperphosphatemia after sodium phosphate laxatives in low risk patients: prospective study.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=20014460&dopt=Abstract
Carcinoma of the middle bile duct: is bile duct segmental resection appropriate?
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=20014461&dopt=Abstract
Percutaneous transgastric computed tomography-guided biopsy of the pancreas using large needles.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=20014462&dopt=Abstract
Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=20014463&dopt=Abstract
Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=20014464&dopt=Abstract
Editor, Clinical Gastroenterology & Hepatology.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=20117246&dopt=Abstract
Level of Fellowship Training Increases Adenoma Detection Rates.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=20117245&dopt=Abstract
Continuous Therapy With Certolizumab Pegol Maintains Remission of Patients With Crohn's Disease for up to 18 Months.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=20117244&dopt=Abstract
Success of self-administered home fecal transplantation for chronic Clostridium difficile infection.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=20117243&dopt=Abstract
Langerhans cell histiocytosis of the stomach mimicking early gastric cancer.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=20117242&dopt=Abstract
High risk ulcer bleeding: when is second look endoscopy recommended?
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=20117241&dopt=Abstract
What are the risks of general surgical abdominal operations in patients with cirrhosis?
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=20117240&dopt=Abstract
Diaphragm-like stricture of the small intestine related to cytomegalovirus infection.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=20117239&dopt=Abstract
The expanding role of biologic therapy for IBD
http://feeds.nature.com/~r/nrgastro/rss/current/~3/JFrw0Hz3bvE/nrgastro.2009.238
IBD: High dietary intake of linoleic acid more than doubles the risk of ulcerative colitis
http://feeds.nature.com/~r/nrgastro/rss/current/~3/TvYxeicQ6q8/nrgastro.2009.224
H. Hepaticus and biliary disease
http://feeds.nature.com/~r/nrgastro/rss/current/~3/wQcBFsrtrH0/nrgastro.2009.229
Pancreas: New antibody may aid diagnosis of autoimmune pancreatitis
http://feeds.nature.com/~r/nrgastro/rss/current/~3/NkwWKyJJyQY/nrgastro.2009.230
Obesity: Lifestyle counseling ineffective in tackling childhood obesity
http://feeds.nature.com/~r/nrgastro/rss/current/~3/amSggaFaNWg/nrgastro.2009.226
IBD: Thiopurines increase risk of lymphoproliferative disorders in patients with IBD
http://feeds.nature.com/~r/nrgastro/rss/current/~3/GzGNhifhpFU/nrgastro.2009.227
Obesity: Liraglutide induces weight loss
http://feeds.nature.com/~r/nrgastro/rss/current/~3/qEXhGB1gyos/nrgastro.2009.228
Gallstones: Statin use is associated with a reduced risk of cholesterol gallstones
http://feeds.nature.com/~r/nrgastro/rss/current/~3/0v7hugQRHhM/nrgastro.2009.231
Hepatic artery thrombosis
http://feeds.nature.com/~r/nrgastro/rss/current/~3/KIUpfuYXvMA/nrgastro.2009.223
IBD: Is treatment with a third anti-TNF agent a safe and effective option in patients with Crohn's disease?
http://feeds.nature.com/~r/nrgastro/rss/current/~3/E7DJwdv6Gno/nrgastro.2009.225
IBD: Intensive GMA is more efficacious than weekly GMA for the treatment of ulcerative colitis
http://feeds.nature.com/~r/nrgastro/rss/current/~3/PWS_SP5rFRk/nrgastro.2009.239
GERD: Are functional heartburn and functional dyspepsia one disorder?
http://feeds.nature.com/~r/nrgastro/rss/current/~3/AdxKteCucx8/nrgastro.2009.233
Pancreas: Is there still a role for total pancreatectomy?
http://feeds.nature.com/~r/nrgastro/rss/current/~3/-hwsnj9qnj8/nrgastro.2009.234
Primary sclerosing cholangitis: What is the role of ursodeoxycholic acid in therapy for PSC?
http://feeds.nature.com/~r/nrgastro/rss/current/~3/6XbxW__Dlok/nrgastro.2009.235
Liver: Management of non-acetaminophen-induced ALF
http://feeds.nature.com/~r/nrgastro/rss/current/~3/caQFueSoVlk/nrgastro.2009.236
Diverticular disease: What is the best long-term treatment?
http://feeds.nature.com/~r/nrgastro/rss/current/~3/HThTj-d5SYQ/nrgastro.2009.237
The potential for disease modification in Crohn's disease
http://feeds.nature.com/~r/nrgastro/rss/current/~3/B1w_heYkg1k/nrgastro.2009.220
Top-down therapy for IBD: rationale and requisite evidence
http://feeds.nature.com/~r/nrgastro/rss/current/~3/Te9X2f3JLcw/nrgastro.2009.222
Optimizing the safety of biologic therapy for IBD
http://feeds.nature.com/~r/nrgastro/rss/current/~3/6HSvarjCaLc/nrgastro.2009.221
The pharmacoeconomics of biologic therapy for IBD
http://feeds.nature.com/~r/nrgastro/rss/current/~3/28nyTwXmuFU/nrgastro.2009.232
Future biologic targets for IBD: potentials and pitfalls
http://feeds.nature.com/~r/nrgastro/rss/current/~3/FvAvGOIQ-z4/nrgastro.2009.218
Increased expression and cellular localization of spermine oxidase in ulcerative colitis and relationship to disease activity
http://dx.doi.org/10.1002%2Fibd.21224
Inflammatory bowel diseases and health service: The necessity for a new strategy
http://dx.doi.org/10.1002%2Fibd.21216
Final adult height of children with inflammatory bowel disease is predicted by parental height and patient minimum height Z-score
http://dx.doi.org/10.1002%2Fibd.21214
Controversy over NOD2, inflammation, and defensins
http://dx.doi.org/10.1002%2Fibd.21213
New proteomic approaches for biomarker discovery in inflammatory bowel disease
http://dx.doi.org/10.1002%2Fibd.21212
Treatment-associated acute myeloid leukemia in a patient with Crohn's disease on 6-mercaptopurine
http://dx.doi.org/10.1002%2Fibd.21205
Lewis and Sumner syndrome following infliximab treatment in Crohn's disease: A report of 2 cases
http://dx.doi.org/10.1002%2Fibd.21202
Response to Baumgart review
http://dx.doi.org/10.1002%2Fibd.21201
In vivo analysis of gut function and disease changes in a zebrafish larvae model of inflammatory bowel disease: A feasibility study
http://dx.doi.org/10.1002%2Fibd.21200
Simple score to identify colectomy risk in ulcerative colitis hospitalizations
http://dx.doi.org/10.1002%2Fibd.21225
To TNF or not to TNF: That is the question
http://dx.doi.org/10.1002%2Fibd.21203
Phase I trial of sargramostim in pediatric Crohn's disease
http://dx.doi.org/10.1002%2Fibd.21204
CD95 is cytoprotective for intestinal epithelial cells in colitis
http://dx.doi.org/10.1002%2Fibd.21195
Cell death in the colonic epithelium during inflammatory bowel diseases: CD95/Fas and beyond
http://dx.doi.org/10.1002%2Fibd.21191
Total nasolacrimal duct obstruction in 2 patients with inflammatory bowel disease
http://dx.doi.org/10.1002%2Fibd.21207
Activated factor XI and tissue factor in inflammatory bowel disease
http://dx.doi.org/10.1002%2Fibd.21206
Evaluation of endoscopic and imaging modalities in the diagnosis of structural disorders of the ileal pouch
http://dx.doi.org/10.1002%2Fibd.21199
Direct comparison of two different mesalamine formulations for the maintenance of remission in patients with ulcerative colitis: A double-blind, randomized study
http://dx.doi.org/10.1002%2Fibd.21194
Direct comparison of two different mesalamine formulations for the induction of remission in patients with ulcerative colitis: A double-blind, randomized study
http://dx.doi.org/10.1002%2Fibd.21193
Thiopurine maintenance therapy for ulcerative colitis: The clinical significance of monitoring 6-thioguanine nucleotide
http://dx.doi.org/10.1002%2Fibd.21190
Surgical management of pyogenic complications of Crohn's disease
http://dx.doi.org/10.1002%2Fibd.20984
Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's disease
http://dx.doi.org/10.1002%2Fibd.21196
Safety of adalimumab in Crohn's disease during pregnancy: Case report and review of the literature
http://dx.doi.org/10.1002%2Fibd.21198
When expression is not enough: The evolving thoughts on Fas/FasL and epithelial cell apoptosis
http://dx.doi.org/10.1002%2Fibd.21197
Mortality in inflammatory bowel disease in the Netherlands 1991-2002: Results of a population-based study: The IBD South-Limburg cohort
http://dx.doi.org/10.1002%2Fibd.21189
Budesonide treatment of patients with collagenous colitis restores normal eosinophil and T-cell activity in the colon
http://dx.doi.org/10.1002%2Fibd.21188
Laparoscopic surgery for recurrent ileocolic Crohn's disease
http://dx.doi.org/10.1002%2Fibd.21186
Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis
http://dx.doi.org/10.1002%2Fibd.21184
Preserved Na+/H+ exchanger isoform 3 expression and localization, but decreased NHE3 function indicate regulatory sodium transport defect in ulcerative colitis
http://dx.doi.org/10.1002%2Fibd.21183
Enhanced expression of proproliferative and antiapoptotic genes in ulcerative colitis-associated neoplasia
http://dx.doi.org/10.1002%2Fibd.21178
Periportal cuffing in inflammatory bowel diseases: Mystery of stars and stripes
http://dx.doi.org/10.1002%2Fibd.21165
Serum anti-glycan antibodies predict complicated Crohn's disease behavior: A cohort study
http://dx.doi.org/10.1002%2Fibd.21179
Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate
http://dx.doi.org/10.1002%2Fibd.21177
Variants at the 3p21 locus influence susceptibility and phenotype both in adults and early-onset patients with inflammatory bowel disease
http://dx.doi.org/10.1002%2Fibd.21176
Should patients under long-term anti-TNF therapies be followed for tuberculosis contamination?
http://dx.doi.org/10.1002%2Fibd.21162
Management of inflammatory bowel diseases: A changing paradigm. Can we finally change the disease course?
http://dx.doi.org/10.1002%2Fibd.21181
Risk of ischemic stroke in patients with Crohn's disease: A population-based nested case-control study
http://dx.doi.org/10.1002%2Fibd.21187
Low-dose naltrexone for treatment of duodenal Crohn's disease in a pediatric patient
http://dx.doi.org/10.1002%2Fibd.21185
Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease
http://dx.doi.org/10.1002%2Fibd.21175
Genome wide association (GWA) predictors of anti-TNF[alpha] therapeutic responsiveness in pediatric inflammatory bowel disease
http://dx.doi.org/10.1002%2Fibd.21174
Elevated IL-13R[alpha]2 in intestinal epithelial cells from ulcerative colitis or colorectal cancer initiates MAPK pathway
http://dx.doi.org/10.1002%2Fibd.21133
Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: Results of the FACTS survey
http://dx.doi.org/10.1002%2Fibd.21127
Ocular manifestations in a community-based cohort of patients with inflammatory bowel disease
http://dx.doi.org/10.1002%2Fibd.21180
3 g per day was associated with an increased odds ratio of dry eyes (OR 15, 95% CI 1.9-122). Active disease was not associated with eye symptoms or dry eyes. Other eye conditions such as episcleritis, uveitis, or cataracts were infrequent in this cohort.Patients with IBD in the community frequently have dry eyes. This is associated with 5-ASA use, particularly doses >3 g per day. Whether this is a surrogate marker of disease severity is unclear. Inflamm Bowel Dis 2010]]>Can fecal calprotectin or lactoferrin identify postoperative recurrence in Crohn's disease?
http://dx.doi.org/10.1002%2Fibd.21173
Interleukin 21 expression is increased in rectal biopsies from patients with ulcerative colitis
http://dx.doi.org/10.1002%2Fibd.21135
CD24 is upregulated in inflammatory bowel disease and stimulates cell motility and colony formation
http://dx.doi.org/10.1002%2Fibd.21134
Quality and publication success of abstracts of randomized clinical trials in inflammatory bowel disease presented at Digestive Disease Week
http://dx.doi.org/10.1002%2Fibd.21131
Nutriose, a prebiotic low-digestible carbohydrate, stimulates gut mucosal immunity and prevents TNBS-induced colitis in piglets
http://dx.doi.org/10.1002%2Fibd.21130
Asymmetric endoscopic inflammation of the ileal pouch: A sign of ischemic pouchitis?
http://dx.doi.org/10.1002%2Fibd.21129
Health-related quality of life of youth with inflammatory bowel disease: A comparison with published data using the PedsQL 4.0 generic core scales
http://dx.doi.org/10.1002%2Fibd.21128
The path to Crohn's disease: Is mucosal pathology a secondary event?
http://dx.doi.org/10.1002%2Fibd.21171
Ulcerative colitis in northern Portugal and Galicia in Spain
http://dx.doi.org/10.1002%2Fibd.21170
Subepithelial dendritic B cells in orofacial granulomatosis
http://dx.doi.org/10.1002%2Fibd.21169
Magnetic resonance follow-through imaging for evaluation of disease activity in ileal Crohn's disease: An observational, retrospective cohort study
http://dx.doi.org/10.1002%2Fibd.21168
Targeting TGF-[beta]1 by employing a vaccine ameliorates fibrosis in a mouse model of chronic colitis
http://dx.doi.org/10.1002%2Fibd.21167
Methotrexate for maintenance of remission in chronic active Crohn's disease: Long-term single-center experience and meta-analysis of observational studies
http://dx.doi.org/10.1002%2Fibd.21166
Impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohn's disease
http://dx.doi.org/10.1002%2Fibd.21164
8 weeks prior to or during maintenance therapy). We examined differences in need for medical and surgical hospitalizations as well as associated healthcare costs between the 2 groups.In all, 104 CD patients met criteria for 3-year maintenance infliximab treatment (SM n = 64; PI n = 40). The rates of CD-related surgeries (60.9% and 55.0%, P = not significant [N.S.]) and medical hospitalizations (35.9% and 37.5%, P = N.S.) prior to infliximab initiation was similar between the 2 groups. However, the rate of medical (26.5% versus 47.5%, P = 0.035) and surgical hospitalizations (21.8% versus 48.7%, P = 0.009) were significantly lower in the SM compared to the PI group. During the third year of treatment the excess costs per patient for the PI group compared to the SM group amounted to $11,464 in spite of both cohorts being on SM therapy.Patients who begin and continue an uninterrupted maintenance dosing regimen had a lower incidence of hospitalization and surgery than those who received an irregular or interrupted regimen prior to beginning an SM regimen. (Inflamm Bowel Dis 2010)]]>Lipopolysaccharide exposure is linked to activation of the acute phase response and growth failure in pediatric Crohn's disease and murine colitis
http://dx.doi.org/10.1002%2Fibd.21132
Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohn's disease
http://dx.doi.org/10.1002%2Fibd.21159
Validation of the Spanish version of a questionnaire to measure quality of care through the eyes of patients with inflammatory bowel disease (QUOTE-IBD)
http://dx.doi.org/10.1002%2Fibd.21156
Single-port access laparoscopic surgery for complex Crohn's disease
http://dx.doi.org/10.1002%2Fibd.21163
Outcome of medical treatment of stricturing and penetrating Crohn's disease: A retrospective study
http://dx.doi.org/10.1002%2Fibd.21160
TLR9 mRNA expression is upregulated in patients with active ulcerative colitis
http://dx.doi.org/10.1002%2Fibd.21155
Angiopoietin-2 in experimental colitis
http://dx.doi.org/10.1002%2Fibd.21150
Fine-scale geographic variations of inflammatory bowel disease in France: Correlation with socioeconomic and house equipment variables
http://dx.doi.org/10.1002%2Fibd.21122
Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis
http://dx.doi.org/10.1002%2Fibd.21161
Babesiosis in a patient on infliximab for Crohn's disease
http://dx.doi.org/10.1002%2Fibd.21158
Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohn's disease
http://dx.doi.org/10.1002%2Fibd.21157
Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding
http://dx.doi.org/10.1002%2Fibd.21154
Diagnostic value of noninvasive combined fluorine-18 labeled fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography enterography in active Crohn's disease
http://dx.doi.org/10.1002%2Fibd.21153
Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France
http://dx.doi.org/10.1002%2Fibd.21147
Tissue factor -1208D>I polymorphism is associated with D-dimer levels in patients with inflammatory bowel disease
http://dx.doi.org/10.1002%2Fibd.21149
Novel model of TH2-polarized chronic ileitis: The SAMP1 mouse
http://dx.doi.org/10.1002%2Fibd.21148
Cdcs1 a major colitis susceptibility locus in mice; Subcongenic analysis reveals genetic complexity
http://dx.doi.org/10.1002%2Fibd.21146
MDP-NOD2 stimulation induces HNP-1 secretion, which contributes to NOD2 antibacterial function
http://dx.doi.org/10.1002%2Fibd.21144
Surgery for low-grade colorectal dysplasia in ulcerative colitis: Decisions, decisions
http://dx.doi.org/10.1002%2Fibd.21138
A33 antigen-deficient mice have defective colonic mucosal repair
http://dx.doi.org/10.1002%2Fibd.21114
TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohn's disease
http://dx.doi.org/10.1002%2Fibd.21124
Natural history of Crohn's disease: Comparison between childhood- and adult-onset disease
http://dx.doi.org/10.1002%2Fibd.21152
Interleukin-19 protects mice from innate-mediated colonic inflammation
http://dx.doi.org/10.1002%2Fibd.21151
Inflammatory bowel disease in young people: The case for transitional clinics
http://dx.doi.org/10.1002%2Fibd.21145
Genome-wide gene expression analysis of mucosal colonic biopsies and isolated colonocytes suggests a continuous inflammatory state in the lamina propria of patients with quiescent ulcerative colitis
http://dx.doi.org/10.1002%2Fibd.21142
Magnetic resonance imaging for Crohn's disease: Is this really the end of colonoscopy?
http://dx.doi.org/10.1002%2Fibd.21141
The good, the bad, and the ugly: Adverse events and Crohn's therapies
http://dx.doi.org/10.1002%2Fibd.21139
Perianal fistulae in Crohn's Disease: Current and future approaches to treatment
http://dx.doi.org/10.1002%2Fibd.21137
Fecal calprotectin variability in Crohn's disease
http://dx.doi.org/10.1002%2Fibd.21136
Colocolic intussusception in a patient with ulcerative colitis
http://dx.doi.org/10.1002%2Fibd.21123
Clostridium difficile and inflammatory bowel disease: More questions than answers?
http://dx.doi.org/10.1002%2Fibd.21140
Crohn's disease patient with right lower quadrant abdominal pain for 20 years due to an appendiceal neuroma (Fibrous obliteration of the appendix)
http://dx.doi.org/10.1002%2Fibd.21143
Ulcerative colitis in a Southern European country: A national perspective
http://dx.doi.org/10.1002%2Fibd.21119
Cerebral thromboembolic events in pediatric patients with inflammatory bowel disease
http://dx.doi.org/10.1002%2Fibd.21113
Association between blood flow and inflammatory state in a T-cell transfer model of inflammatory bowel disease in mice
http://dx.doi.org/10.1002%2Fibd.21126
Turner's syndrome, autoimmune thyroiditis, and Crohn's disease in the same patient: A combination emphasizing the role of X-chromosome in inflammatory bowel disease patients
http://dx.doi.org/10.1002%2Fibd.21125
Recurrent cytomegalovirus infection in ileal pouch-anal anastomosis for ulcerative colitis
http://dx.doi.org/10.1002%2Fibd.21121
Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohn's disease
http://dx.doi.org/10.1002%2Fibd.21117
The position of the amino group on the benzene ring is critical for mesalamine's improvement of replication fidelity
http://dx.doi.org/10.1002%2Fibd.21112
Pityriasis lichenoides chronica induced by adalimumab therapy for Crohn's disease: Report of 2 cases successfully treated with methotrexate
http://dx.doi.org/10.1002%2Fibd.21110
Relationships between inflammatory bowel disease and perinatal factors: Both maternal and paternal disease are related to preterm birth of offspring
http://dx.doi.org/10.1002%2Fibd.21120
Small bowel resection rates in Crohn's disease and the indication for surgery over time: Experience from a large tertiary care center
http://dx.doi.org/10.1002%2Fibd.21118
Perforin deficiency attenuates inflammation and tumor growth in colitis-associated cancer
http://dx.doi.org/10.1002%2Fibd.21107
Mapping of inflammatory bowel disease in northern France: Spatial variations and relation to affluence
http://dx.doi.org/10.1002%2Fibd.21111
Transmission ratio distortion of DLG5 R30Q: Evidence for prenatal selection?
http://dx.doi.org/10.1002%2Fibd.21109
Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: A transport deficiency
http://dx.doi.org/10.1002%2Fibd.21108
CXCL12 Is a constitutive and inflammatory chemokine in the intestinal immune system
http://dx.doi.org/10.1002%2Fibd.21106
Crohn's disease [CD], inflamed > noninflamed). CXCR4 was expressed by IECs, LP T cells (LPTs), and PB T cells (PBTs), and CXCR4+ cells were increased in IBD LP in situ. PBTs and LPTs from all patients had a high and comparable migration toward CXCL12 (P < 0.0001 and P < 0.05 vs. medium, respectively). Migration toward IBD-IEC-derived supernatant was significantly higher compared to normal. Antibodies against CXCR4 and CXCL12 blocked migration.CXCL12 is expressed by normal IECs and upregulated and differentially distributed in IBD IECs. CXCR4 is expressed by IECs and LPTs, and CXCR4+ cells are significantly increased in IBD LP. CXCL12 is chemotactic for both PBTs and LPTs. Thus, CXCL12 and CXCR4 have a constitutive and inflammatory role in the intestinal mucosa and their selective therapeutic manipulation may be considered in IBD management. (Inflamm Bowel Dis 2009;)]]>Does psychological counseling alter the natural history of inflammatory bowel disease?
http://dx.doi.org/10.1002%2Fibd.21098
1 session counseling helped solve stress-related difficulties (counselor's score 4 [3-5]), the counselor scored them 4 (3-6) overall in psychological well-being after the counseling sessions.IBD-focused counseling may improve not only psychological well-being, but also the course of IBD in individuals with psychosocial stress. (Inflamm Bowel Dis 2009;)]]>TLR5 is not required for flagellin-mediated exacerbation of DSS colitis
http://dx.doi.org/10.1002%2Fibd.21097
5-aminosalicylic acid interferes in the cell cycle of colorectal cancer cells and induces cell death modes
http://dx.doi.org/10.1002%2Fibd.21086
Association between Helicobacter pylori infection and inflammatory bowel disease: A meta-analysis and systematic review of the literature
http://dx.doi.org/10.1002%2Fibd.21116
Analysis of 39 Crohn's disease risk loci in Swedish inflammatory bowel disease patients
http://dx.doi.org/10.1002%2Fibd.21105
Epstein-Barr virus and parvovirus B19 coinfection in a Crohn's disease patient under azathioprine
http://dx.doi.org/10.1002%2Fibd.21104
Ileal pouch for everyone, even when we are not sure of the diagnosis before or at colectomy?
http://dx.doi.org/10.1002%2Fibd.21103
Body mass index and disease activity at treatment initiation: Potential new predictors of response to azathioprine therapy in IBD
http://dx.doi.org/10.1002%2Fibd.21102
Current thinking on recurrence: Does anastomotic surgical technique affect recurrence rates in Crohn's patients?
http://dx.doi.org/10.1002%2Fibd.21100
Incidence of stricturing and penetrating complications of Crohn's disease diagnosed in pediatric patients
http://dx.doi.org/10.1002%2Fibd.21099
Plasma chromogranin A in patients with inflammatory bowel disease: A possible explanation
http://dx.doi.org/10.1002%2Fibd.21096
Effect of EP4 agonist (ONO-4819CD) for patients with mild to moderate ulcerative colitis refractory to 5-aminosalicylates: A randomized phase II, placebo-controlled trial
http://dx.doi.org/10.1002%2Fibd.21080
Lessons from geographic mapping of IBD in France
http://dx.doi.org/10.1002%2Fibd.21115
Adalimumab for cutaneous metastatic Crohn's disease
http://dx.doi.org/10.1002%2Fibd.21082
Getting the steak without the sizzle: Is MR enterography as good as CT enterography?
http://dx.doi.org/10.1002%2Fibd.21101
Antigen-presenting cells exposed to Lactobacillus acidophilus NCFM, Bifidobacterium bifidum BI-98, and BI-504 reduce regulatory T cell activity
http://dx.doi.org/10.1002%2Fibd.21068
Age distribution of IBD hospitalization
http://dx.doi.org/10.1002%2Fibd.21055
Widespread but not localized neoplasia in inflammatory bowel disease worsens the prognosis of colorectal cancer
http://dx.doi.org/10.1002%2Fibd.21053
High gene expression of MDR1 (ABCB1) is associated with medical treatment response and long-term remission in patients with ulcerative colitis
http://dx.doi.org/10.1002%2Fibd.21016
A new tool to measure the burden of Crohn's disease and its treatment: Do patient and physician perceptions match?
http://dx.doi.org/10.1002%2Fibd.21094
Platelet-activating factor-induced NF-[kappa]B activation and IL-8 production in intestinal epithelial cells are Bcl10-dependent
http://dx.doi.org/10.1002%2Fibd.21092
Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease
http://dx.doi.org/10.1002%2Fibd.21091
Female gender and surgery impair relationships, body image, and sexuality in inflammatory bowel disease: Patient perceptions
http://dx.doi.org/10.1002%2Fibd.21090
Crohn's proctitis: A distinct entity
http://dx.doi.org/10.1002%2Fibd.21089
Mesalamine (pentasa)-induced painful skin lesions
http://dx.doi.org/10.1002%2Fibd.21087
Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis
http://dx.doi.org/10.1002%2Fibd.21084
Course of inflammatory bowel disease in patients infected with human immunodeficiency virus
http://dx.doi.org/10.1002%2Fibd.21077
Glucocorticoid bioactivity does not predict response to steroid therapy in severe pediatric ulcerative colitis
http://dx.doi.org/10.1002%2Fibd.21070
Oral valganciclovir for colonic dilatation in ulcerative colitis associated with human cytomegalovirus infection
http://dx.doi.org/10.1002%2Fibd.21081
Detailed haplotype-tagging study of germline variation of MUC19 in inflammatory bowel disease
http://dx.doi.org/10.1002%2Fibd.21074
T-cell regulation of neutrophil infiltrate at the early stages of a murine colitis model
http://dx.doi.org/10.1002%2Fibd.21073
Guillain-Barré syndrome during a relapse of ulcerative colitis: A case report
http://dx.doi.org/10.1002%2Fibd.21071
Age distribution of IBD hospitalization
http://dx.doi.org/10.1002%2Fibd.21058
Effect of natural commensal-origin DNA on toll-like receptor 9 (TLR9) signaling cascade, chemokine IL-8 expression, and barrier integritiy of polarized intestinal epithelial cells
http://dx.doi.org/10.1002%2Fibd.21057
Assessing disease activity in ulcerative colitis: Patients or their physicians?
http://dx.doi.org/10.1002%2Fibd.21088
Value of fractional exhaled nitric oxide (FENO) for the diagnosis of pulmonary involvement due to inflammatory bowel disease
http://dx.doi.org/10.1002%2Fibd.21085
Azathioprine maintains long-term steroid-free remission through 3 years in patients with steroid-dependent ulcerative colitis
http://dx.doi.org/10.1002%2Fibd.21083
Prevalence of Clostridium difficile infection in Polish pediatric patients with inflammatory bowel disease
http://dx.doi.org/10.1002%2Fibd.21056
Mind-body complementary alternative medicine use and quality of life in adolescents with inflammatory bowel disease
http://dx.doi.org/10.1002%2Fibd.21045
Significant association of appendiceal neoplasms and ulcerative colitis rather than Crohn's disease
http://dx.doi.org/10.1002%2Fibd.21095
Exposure of mouse colon to dietary bile acid supplement induces sessile adenomas
http://dx.doi.org/10.1002%2Fibd.21079
On the role of ischemia in the pathogenesis of IBD: A review
http://dx.doi.org/10.1002%2Fibd.21061
Veto on vedolizumab (MLN0002) for Crohn's disease
http://dx.doi.org/10.1002%2Fibd.21078
Fecal calprotectin mirrors inflammation of the distal ileum and bowel function after restorative proctocolectomy for pediatric-onset ulcerative colitis
http://dx.doi.org/10.1002%2Fibd.21069
100 [mu]g/g) fecal calprotectin (669 ± 866 [mu]g/g), although their serum C-reactive protein (5.2 ± 3.8 mg/L), erythrocyte sedimentation rate (13 ± 13 mm/h), and white blood cell count (6.7 ± 1.7 E9/L) were normal or slightly elevated. Calprotectin correlated positively with the histological neutrophil count of the distal ileum (r = 0.715; P < 0.001), the frequency of pouchitis (r = 0.468; P < 0.01), and with the maximum daily frequency of bowel actions (r = 0.610; P < 0.001). Mean fecal calprotectin was 71 ± 50 [mu]g/g among patients with no history of pouchitis (n = 10), 290 ± 131 [mu]g/g among patients with a single episode of pouchitis (n = 15), and 832 ± 422 [mu]g/g among those with recurrent pouchitis (P = 0.019 between recurrent pouchitis and no pouchitis). Sensitivity, specificity, positive predictive value, and negative predictive value for fecal calprotectin concentration over 300 [mu]g/g to detect recurrent pouchitis were 57%, 92%, 67%, and 89%, respectively.Neutrophilic inflammation of the distal ileum, as reflected by fecal calprotectin, is common after restorative proctocolectomy for pediatric-onset UC. Inflamm Bowel Dis 2009]]>Cytokine mRNA expression in steroid-naïve patients with ulcerative colitis
http://dx.doi.org/10.1002%2Fibd.21075
Endoscopic ultrasound to guide the combined medical and surgical management of pediatric perianal Crohn's disease
http://dx.doi.org/10.1002%2Fibd.21067
Similar geographic variations of mortality and hospitalization associated with IBD and Clostridium difficile colitis
http://dx.doi.org/10.1002%2Fibd.21054
Does primary sclerosing cholangitis impact quality of life in patients with inflammatory bowel disease?
http://dx.doi.org/10.1002%2Fibd.21051
Need for standardization in population-based quality of life studies: A review of the current literature
http://dx.doi.org/10.1002%2Fibd.21032
Sulfasalazine-induced nephrotic syndrome in a patient with ulcerative colitis
http://dx.doi.org/10.1002%2Fibd.21049
TNF-[alpha] is an important pathogenic factor contributing to reactivation of cytomegalovirus in inflamed mucosa of colon in patients with ulcerative colitis: Lesson from clinical experience
http://dx.doi.org/10.1002%2Fibd.21047
Development of glomerulonephritis early in the course of Crohn's disease
http://dx.doi.org/10.1002%2Fibd.21044
Gastrointestinal manifestations in primary immune disorders
http://dx.doi.org/10.1002%2Fibd.21040
Salmonella septic arthritis in a patient with Crohn's disease on infliximab
http://dx.doi.org/10.1002%2Fibd.21033
Acute lymphoid leukemia in a Crohn's disease patient during treatment with adalimumab after a prolonged treatment with azathioprine and steroids
http://dx.doi.org/10.1002%2Fibd.21005
Granulocyte-macrophage colony-stimulating factor elicits bone marrow-derived cells that promote efficient colonic mucosal healing
http://dx.doi.org/10.1002%2Fibd.21072
Severe sporotrichoid fishtank granuloma following infliximab therapy for Crohn's disease
http://dx.doi.org/10.1002%2Fibd.21009
Splenic tuberculosis in a patient with Crohn's disease on infliximab: Case report
http://dx.doi.org/10.1002%2Fibd.20998
Sterile seroma after surgical drainage of purulent psoas abscess in Crohn's disease
http://dx.doi.org/10.1002%2Fibd.21020
Potential for amino acids supplementation during inflammatory bowel diseases
http://dx.doi.org/10.1002%2Fibd.21017
Cerebral venous thrombosis in inflammatory bowel diseases
http://dx.doi.org/10.1002%2Fibd.20996
Does methotrexate induce mucosal healing in Crohn's disease?
http://dx.doi.org/10.1002%2Fibd.21015
Atrioventricular block associated with Crohn's relapsing colitis in a 12-year-old child
http://dx.doi.org/10.1002%2Fibd.21006
Elevated serum chromogranin A in irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD): A shared model for pathogenesis?
http://dx.doi.org/10.1002%2Fibd.20982
Current smoking, not duration of remission, delays Crohn's disease relapse following azathioprine withdrawal
http://dx.doi.org/10.1002%2Fibd.20981
Varicella pneumonia in an immunocompromised inflammatory bowel disease patient
http://dx.doi.org/10.1002%2Fibd.20980
Endoscopic healing should be a goal for everyone with ulcerative colitis
http://dx.doi.org/10.1002%2Fibd.20779